MapLight Therapeutics Co-Founder Dr. Karl Deisseroth Wins 2026 Nobel Prize in Medicine
MapLight Therapeutics (MPLT) announced that its co-founder, Dr. Karl Deisseroth, has been awarded the 2026 Nobel Prize in Physiology or Medicine alongside another recipient. The award was conferred by Sweden’s Karolinska Institute through its Nobel Assembly. Dr. Deisseroth is a key figure at MapLight and serves on its Scientific Advisory Board. This recognition highlights his significant contributions to medical science, which could enhance the company's credibility and attract further investment in its research initiatives. The news may also elevate investor confidence due to the association with groundbreaking scientific achievement. The Nobel Prize win is likely to generate positive media attention for MapLight Therapeutics and potentially increase interest from both institutional investors and pharmaceutical partners.
Tickers: $MPLT